Pay in 4 interest-free payments of $90.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
(2012) Journal of Medicinal Chemistry
Smiles: C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=CC(O)=C4C(=O)C[C@H](OC4=C3)C3=CC(OC)=C(C=C3)OC)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
InChi: InChI=1S/C24H23N3O3S/c1-14-8-9-21(15(2)12-14)30-11-10-27-16(3)18(17-6-4-5-7-20(17)27)13-19-22(28)25-24(31)26-23(19)29/h4-9
Gregory Gatouillat
When the MDA-MB-231 cells are treated with 0
Verrucarin A Size:2mg solid (2012) Journal of Medicinal ChemistryVerrucarin A (Muconomycin A), a Type D macrocyclic mycotoxin derived from the pathogen fungus Myrothecium verrucaria, is an inhibitor of protein synthesis. Verrucarin A inhibits growth of leukemia cell lines and activates caspases and apoptosis and inflammatory signaling in macrophages. Verrucarin A effectively increased the phosphorylation of p38 MAPK and diminished the phosphorylation of ERK Akt. Verrucarin A caused cell cycle deregulation through
US$ 24.99
US$ 27.00
US$ 26.00
US$ 27.00
US$ 16.00